We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 2,772 results
  1. Dose-dependent renoprotective effect of vanillic acid on methotrexate-induced nephrotoxicity via its anti-apoptosis, antioxidant, and anti-inflammatory properties

    Methotrexate-induced nephrotoxicity is a medical emergency which is associated with a variety of side effects. Vanillic acid (VA), as an antioxidant,...

    Negin Amini, Mahla Hassanzadeh Shoshtari, ... Mohammad Badavi in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 02 December 2023
  2. Molecular mechanisms underlying methotrexate-induced intestinal injury and protective strategies

    Methotrexate (MTX) is a folic acid reductase inhibitor that manages various malignancies as well as immune-mediated inflammatory chronic diseases....

    Gaber F. Ali, Emad H. M. Hassanein, Wafaa R. Mohamed in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article Open access 01 June 2024
  3. Methotrexate in generalized myasthenia gravis: a systematic review

    Current myasthenia gravis guidelines recommend the use of azathioprine as first-line steroid sparing agent. However, due to its high cost, compliance...

    Mario B. Prado Jr, Karen Joy B. Adiao in Acta Neurologica Belgica
    Article 27 March 2023
  4. Factors influencing methotrexate pharmacokinetics highlight the need for individualized dose adjustment: a systematic review

    Purpose

    To develop a population pharmacokinetic (PPK) model for methotrexate (MTX) dosage for all ages, assess the association between concentration...

    Yunyun Yang, Zhengyue Liu, ... Zhuo Wang in European Journal of Clinical Pharmacology
    Article 07 November 2023
  5. Antioxidant and anti-inflammatory potential of spirulina and thymoquinone mitigate the methotrexate-induced neurotoxicity

    The objective of this study was to investigate whether the neurotoxic effects caused by methotrexate (MTX), a frequently used chemotherapy drug,...

    Alaa Behairy, Ashraf Elkomy, ... Mohamed Aboubakr in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article Open access 29 September 2023
  6. Rhein methotrexate-decorated solid lipid nanoparticles altering adjuvant arthritis progression through endoplasmic reticulum stress-mediated apoptosis

    Methotrexate (MTX) and diacerein (DIA) are two of the most potent disease-modifying anti-rheumatic drugs used for the treatment of rheumatoid...

    Wessam M. El-Refaie, Mostafa S. Ghazy, ... Mennatallah A. Gowayed in Inflammopharmacology
    Article Open access 01 August 2023
  7. Development of pH-Sensitive Nanoparticle Incorporated into Dissolving Microarray Patch for Selective Delivery of Methotrexate

    Purpose

    Rheumatoid arthritis (RA) is a systemic autoimmune disease that attacks human joints. Methotrexate (MTX), as one the most effective...

    Nur Qadri Febrianti, Anugerah Yaumil Ramadhani Aziz, ... Andi Dian Permana in AAPS PharmSciTech
    Article 27 March 2024
  8. Methotrexate conjugated gold nanoparticles improve rheumatoid vascular dysfunction in rat adjuvant-induced arthritis: gold revival

    Endothelial vasomotor dysfunction and accelerated atherosclerosis encompass the features of rheumatoid vascular dysfunction (RVD), increasing...

    Salma T. Rafik, Teshreen M. Zeitoun, ... Cherine A. Ismail in Inflammopharmacology
    Article Open access 08 December 2022
  9. Examining hepatoprotective effects of astaxanthin against methotrexate-induced hepatotoxicity in rats through modulation of Nrf2/HO-1 pathway genes

    Methotrexate (MTX), as a folic acid antagonist, is an effective drug in treating a wide range of malignancies and autoimmune diseases. However, the...

    Razieh Azadian, Adel Mohammadalipour, ... Mohammad Hosein Aarabi in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 14 July 2023
  10. Methotrexate-induced intestine and nephrotoxicity attenuated by Andrographis paniculata via ameliorating oxidative stress, inflammation and apoptosis

    The therapeutical benefits of methotrexate (MTX) antifolate agents are non-negligible. However, their ability to cause severe intestinal and...

    Manisha Parthasarathy, Sabina Evan Prince in Advances in Traditional Medicine
    Article 07 November 2023
  11. First-line induction chemotherapy with high-dose methotrexate versus teniposide in patients with newly diagnosed primary central nervous system lymphoma: a retrospective, multicenter cohort study

    Background

    This study aimed to compare the efficacy and safety of high-dose methotrexate (HD-MTX) versus teniposide (TEN) in patients with newly...

    Kaili Zhong, Yanyan Shi, ... Wei**g Zhang in BMC Cancer
    Article Open access 11 August 2023
  12. Elecampane rhizome extract alleviates methotrexate-induced hepatotoxicity and nephrotoxicity in male rats

    Methotrexate (MTX) is a chemotherapy drug used to treat cancer and inflammatory diseases; however, its clinical applicability is limited due to its...

    Fatemeh Sharifi, Vahid Jazi, Elham Assadi Soumeh in Advances in Traditional Medicine
    Article 16 February 2023
  13. Role of Nrf2/HO-1, PPAR-γ, and cytoglobin signals in the pathogenesis of methotrexate-induced testicular intoxication in rats and the protective effect of diacerein

    Methotrexate (MTX) is an inhibitor of folic acid reductase used in managing a variety of malignancies. Testicular injury by MTX is one of its serious...

    Mustafa Ahmed Abdel-Reheim, Gaber F. Ali, ... Wafaa R. Mohamed in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 07 December 2023
  14. Beneficial effect of temporary methotrexate interruption on B and T cell responses upon SARS-CoV-2 vaccination in patients with rheumatoid arthritis or psoriatic arthritis

    B and T cell responses were evaluated in patients with rheumatoid arthritis (RA) or psoriatic arthritis (PsA) after 1 or 2 weeks of methotrexate...

    Pedro Martínez-Fleta, Esther F. Vicente-Rabaneda, ... Santos Castañeda in npj Vaccines
    Article Open access 30 January 2024
  15. Understanding hemoglobin contribution to high-dose methotrexate disposition—population pharmacokinetics in pediatric patients with hematological malignancies

    Purpose

    The aim of the present study was to develop a population pharmacokinetic model for methotrexate (MTX) during high-dose treatment (HDMTX) in...

    Biljana Škorić, Marija Jovanović, ... Katarina Vučićević in European Journal of Clinical Pharmacology
    Article 12 February 2024
  16. Use of methotrexate and risk of skin cancer: a nationwide case–control study

    Background

    Methotrexate (MTX) use has been suspected of increasing the risk of skin cancer. The aim of this investigation was to examine the...

    Sam Polesie, Martin Gillstedt, ... Kasper Kristensen in British Journal of Cancer
    Article Open access 04 February 2023
  17. Formulation, Characterization, and Optimization of Transethosomes for Enhanced Transdermal Delivery of Methotrexate

    Purpose

    Methotrexate (MTX) is an antineoplastic drug used in the treatment of rheumatoid arthritis (RA). Given that it is a class IV drug with low...

    Priyanka J. Veer, Vinayak S. Mastiholimath in Journal of Pharmaceutical Innovation
    Article 27 December 2023
  18. MTX-PEG-modified CG/DMMA polymeric micelles for targeted delivery of doxorubicin to induce synergistic autophagic death against triple-negative breast cancer

    The chemotherapy of triple-negative breast cancer based on doxorubicin (DOX) regimens suffers from great challenges on toxicity and autophagy raised...

    Zhiwen Cao, Rui Liu, ... Yuanyan Liu in Breast Cancer Research
    Article Open access 12 January 2023
  19. Drug-drug interaction assessment based on a large-scale spontaneous reporting system for hepato- and renal-toxicity, and thrombocytopenia with concomitant low-dose methotrexate and analgesics use

    Background

    Methotrexate (MTX) is the cornerstone of rheumatoid arthritis (RA) treatment and is highly effective with low-dose intermittent...

    Takeshi Honma, Kenji Onda, Koichi Masuyama in BMC Pharmacology and Toxicology
    Article Open access 01 February 2024
  20. Zinc and L-carnitine combination with or without methotrexate prevents intestinal toxicity during arthritis treatment via Nrf2/Sirt1/Foxo3 pathways: an In vivo and molecular docking approach

    Methotrexate (MTX) is an antifolate that is inescapable and widely used to treat autoimmune diseases and is the gold standard medicine for the...

    Ramkumar Katturajan, Sabina Evan Prince in Inflammopharmacology
    Article 05 July 2023
Did you find what you were looking for? Share feedback.